A Phase 2 interventional study of I-BiTTM game and Non-I-BiTTM game in Amblyopia, sponsored by Nottingham University Hospitals NHS Trust. Completed at 2 sites in United Kingdom. Open to participants aged 4 Years to 8 Years. Per ClinicalTrials.gov, last updated 2016-11-22.
Sponsored by Nottingham University Hospitals NHS Trust · Phase 2, Interventional, and Treatment
The study aims to determine whether 30 minutes of treatment playing an interactive computer game weekly for 6 weeks, improves visual acuity. The game has been specially configured to ensure the amblyopic eye is preferentially stimulated and the patient wears shutter glasses which manipulate the image seen by each eye in order to provide more information to the amblyopic eye. Patients will be randomised to play the computer game using the I-BiTTM technology, play the computer game but without the I-BiTTM technology, or watch a DVD using the I-BiTTM technology.
183 studies on the registry are indexed under Amblyopia; 43 are open to participants now.
This study's enrollment of 75 is above the median of 60 across 133 interventional studies indexed under Amblyopia.
Browse Amblyopia studies →Nottingham University Hospitals NHS Trust is the lead sponsor of 104 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
30 minutes intervention weekly for 6 weeks.
Device: I-BiTTM game
30 minutes intervention weekly for 6 weeks.
Device: Non-I-BiTTM game
30 minutes intervention weekly for 6 weeks.
Device: I-BiTTM DVD
30 minutes intervention weekly for 6 weeks.
30 minutes intervention weekly for 6 weeks.
30 minutes intervention weekly for 6 weeks.
Change from baseline in visual acuity
Time frame: 6 weeks
Change from baseline in visual acuity
Time frame: 10 weeks
This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nottingham University Hospitals NHS Trust